Minimally required heat doses for various tumour sizes in induction heating cancer therapy determined by computer simulation using experimental data
Authors:
- 8 April 2010
- journal article
- research article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 26 (5) , 465-474
Abstract
Purpose: Although induction heating cancer therapy (IHCT) using magnetic nanoparticles can be a promising approach to treatment-less multi-nodular cancers, the objective requirement for successful clinical application has not clearly been elucidated. We intended to define objective heat doses suitable for IHCT, especially focusing on the sizes of liver cancer nodules. Materials and methods: Alternating magnetic fields were applied to three human pancreatic cancer cell lines, the intercellular space of those cell pellets were filled with magnetic nanoparticles, and confirmed the cytotoxic effect of IHCT. Subsequently, the temperatures of liver cancer nodules in IHCT were simulated using a computer software program and the required heat dose for various sized tumours were determined. Results: Heating the cancer cells up to 50°C for 10 min was sufficient for complete cell killing and the heat dose of 1.7 W/gtumour is required for 10 mm tumour. Larger tumours require a smaller heat dose, e.g. 20 mm and 40 mm tumours require 0.7 W/gtumour and 0.6 W/gtumour, respectively, whereas smaller tumours require large amounts of heat, e.g. 5 mm and 1 mm tumours require 5.1 W/gtumour and 105 W/gtumour, respectively. Conclusions: Integrating the presently available technologies, including high-quality magnetic nanoparticles (1000 W/gmaterial) and effective drug delivery systems (1–2 mgmaterial/gtumour), treatment of a 10 mm tumour seems possible. Since treatment of smaller tumours less than 5 mm require substantial heat dose, researchers involved in IHCT should target cancer nodules of 10 mm or more, and develop a heat delivery system providing a minimum of 1.7 W/gtumour.Keywords
This publication has 33 references indexed in Scilit:
- Local Surgical, Ablative, and Radiation Treatment of MetastasesCA: A Cancer Journal for Clinicians, 2009
- Surgical treatment of liver metastases from pancreatic cancerHPB, 2006
- Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer TherapyClinical Cancer Research, 2005
- Percutaneous Radiofrequency Ablation of Colorectal Hepatic Metastases – Initial ExperienceDigestive Surgery, 2004
- Percutaneous ablation of liver tumoursBest Practice & Research Clinical Gastroenterology, 2004
- Liver metastasis of pancreatic cancer managed by intra-arterial infusion chemotherapy combined with degradable starch microspheresInternational Journal of Clinical Oncology, 2003
- Thermal Ablation Therapy for Focal MalignancyAmerican Journal of Roentgenology, 2000
- Temperature-correlated histo pathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasiaUrology, 1996
- Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinomaCancer, 1994
- Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermiaInternational Journal of Hyperthermia, 1993